Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Song

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Journal of Pediatric Ophthalmology and Strabismus|September 1, 2011
The potential cost-effectiveness of amblyopia screening programsDavid B Rein, John S Wittenborn, Xinzhi Zhang, et al.
Journal of Drugs in Dermatology : JDD|August 21, 2018
Efficacy and Safety of Toreforant, a Selective Histamine H4 Receptor Antagonist, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled TrialEllen Frankel, Michael Song, Shu Li, et al.
Hepatology Communications|March 25, 2025
A systematic review of noninvasive laboratory indices and elastography to predict hepatic decompensationJohn Grady, Michael Song, Whitney Townsend, et al.
American Journal of Botany|March 14, 2018
A novel chloroplast gene reported for flagellate plantsMichael Song, Li-Yaung Kuo, Layne Huiet, et al.
The Journal of Investigative Dermatology|March 10, 2019
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients with Moderate-to-Severe Plaque PsoriasisYaowei Zhu, Joseph C Marini, Michael Song, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque PsoriasisWangda Zhou, Chuanpu Hu, Yaowei Zhu, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2013
Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS)Xuejun Zhu, Min Zheng, Michael Song, et al.
Journal of the American Academy of Dermatology|November 22, 2021
Development of a patient-reported outcome questionnaire to assess signs and symptoms of hidradenitis suppurativa: The Hidradenitis Suppurativa Symptom DiaryAfsaneh Alavi, Sarah Baradaran, Susan D Mathias, et al.
American Journal of Clinical Dermatology|November 13, 2018
Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 StudiesApril W Armstrong, Kristian Reich, Peter Foley, et al.
Biomacromolecules|August 27, 2014
Intracellular trafficking pathways for nuclear delivery of plasmid DNA complexed with highly efficient endosome escape polymersMarianne Gillard, Zhongfan Jia, Jeff Jia Cheng Hou, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Pediatric Ophthalmology and Strabismus|September 1, 2011
The potential cost-effectiveness of amblyopia screening programsDavid B Rein, John S Wittenborn, Xinzhi Zhang, et al.
Journal of Drugs in Dermatology : JDD|August 21, 2018
Efficacy and Safety of Toreforant, a Selective Histamine H4 Receptor Antagonist, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled TrialEllen Frankel, Michael Song, Shu Li, et al.
Hepatology Communications|March 25, 2025
A systematic review of noninvasive laboratory indices and elastography to predict hepatic decompensationJohn Grady, Michael Song, Whitney Townsend, et al.
American Journal of Botany|March 14, 2018
A novel chloroplast gene reported for flagellate plantsMichael Song, Li-Yaung Kuo, Layne Huiet, et al.
The Journal of Investigative Dermatology|March 10, 2019
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients with Moderate-to-Severe Plaque PsoriasisYaowei Zhu, Joseph C Marini, Michael Song, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque PsoriasisWangda Zhou, Chuanpu Hu, Yaowei Zhu, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2013
Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS)Xuejun Zhu, Min Zheng, Michael Song, et al.
Journal of the American Academy of Dermatology|November 22, 2021
Development of a patient-reported outcome questionnaire to assess signs and symptoms of hidradenitis suppurativa: The Hidradenitis Suppurativa Symptom DiaryAfsaneh Alavi, Sarah Baradaran, Susan D Mathias, et al.
American Journal of Clinical Dermatology|November 13, 2018
Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 StudiesApril W Armstrong, Kristian Reich, Peter Foley, et al.
Biomacromolecules|August 27, 2014
Intracellular trafficking pathways for nuclear delivery of plasmid DNA complexed with highly efficient endosome escape polymersMarianne Gillard, Zhongfan Jia, Jeff Jia Cheng Hou, et al.
Pageof 7